Effects of therapeutic agents on cyclic AMP metabolism in vitro.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D002415:Cats; D003345:Corticosterone / Q000096:biosynthesis; D000242:Cyclic AMP / Q000378:metabolism*; D004822:Epididymis / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006868:Hydrolysis; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008053:Lipid Mobilization / Q000187:drug effects; D008168:Lung / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D010600:Pharmacology / Q000502:physiology*; D010726:Phosphodiesterase Inhibitors; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D051381:Rats
D010726:Phosphodiesterase Inhibitors; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; D003345:Corticosterone